Particle.news

Download on the App Store

New Father With Glioblastoma Nears End of Chemoradiation, Pursues Experimental Treatment Abroad

Nearly completing his six-week chemoradiation course, he has raised more than £141,000 to pursue experimental treatments in Germany.

Image
Image

Overview

  • Scans at Oxford’s John Radcliffe Hospital in April confirmed that 42-year-old Elliot Godfrey had a stage-4 glioblastoma days after his son’s first birthday.
  • Surgeons removed roughly 95% of the tumour in a mid-April operation that carried an estimated 20% risk of fatality.
  • He is now nearing the end of a six-week radiotherapy and chemotherapy regimen to address residual cancer cells.
  • His GoFundMe campaign has raised over £141,000 to finance experimental therapies in Germany, including Tumour Treating Fields and dendritic cell vaccines.
  • Alongside medical treatments, Godfrey has overhauled his diet, exercise and wellness practices to optimize his chances of long-term survival.